Modelling the costs and outcomes of changing rates of screening for alcohol misuse by GPs in the Australian context.

abstract：BACKGROUND:There is limited understanding of the health economic implications of cervical screening with human papillomavirus (HPV)-16/18 genotyping. OBJECTIVE:The aim of this study was to evaluate the cost effectiveness of cervical cancer primary screening with a HPV-16/18 genotyping test which simultaneously detects...

journal_title：Applied health economics and health policy

authors： Huh WK,Williams E,Huang J,Bramley T,Poulios N

更新日期：2015-02-01 00:00:00

abstract：:Blockchain technology is a decentralized database that stores a registry of assets and transactions across a peer-to-peer computer network, which is secured through cryptography, and over time, its history gets locked in blocks of data that are cryptographically linked together and secured. So far, there have been use...

journal_title：Applied health economics and health policy

authors： Radanović I,Likić R

更新日期：2018-10-01 00:00:00

abstract：:The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors and pharmacists for rec...

journal_title：Applied health economics and health policy

authors： Yu SY,Yang BM,Kim JH

更新日期：2013-08-01 00:00:00

abstract：BACKGROUND:In Slovenia during the period 2000-2010, the number of years of potential life lost before the age of 70 years per 100,000 population under 70 years of age declined 25 %. OBJECTIVE:The aim of this study was to test the hypothesis that pharmaceutical innovation played a key role in reducing premature mortali...

journal_title：Applied health economics and health policy

authors： Lichtenberg FR

更新日期：2015-04-01 00:00:00

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：:Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of i...

journal_title：Applied health economics and health policy

authors： Macmillan T,Pennington M,Summers JA,Goddard K,Zala D,Herz N,Peacock JL,Keevil S,Chalkidou A

更新日期：2018-12-01 00:00:00

abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...

journal_title：Applied health economics and health policy

authors： Burns DK,Wilson EC,Browne P,Olive S,Clark A,Galey P,Dix E,Woodhouse H,Robinson S,Wilson A

更新日期：2016-02-01 00:00:00

abstract：BACKGROUND:South Korea is unique in that it leads global markets in R&D as well as production of biosimilar products and was the first market into which some biosimilar products were introduced. We analyzed the time trend of market penetration and simulated saved spending by biosimilars in South Korea. METHODS:We pull...

journal_title：Applied health economics and health policy

authors： Lee HJ,Han E,Kim H

更新日期：2020-08-01 00:00:00

abstract：BACKGROUND:The Patient Protection and Affordable Care Act instituted pay-for-performance programs, including Hospital Value-Based Purchasing (HVBP), designed to encourage hospital quality and efficiency. OBJECTIVE AND METHOD:While these programs have been evaluated with respect to their implications for care quality a...

journal_title：Applied health economics and health policy

authors： Izón GM,Pardini CA

更新日期：2018-02-01 00:00:00

abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...

journal_title：Applied health economics and health policy

authors： Tunis SL

更新日期：2011-11-01 00:00:00

abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

journal_title：Applied health economics and health policy

authors： Liu X,Mills A

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Cost-effectiveness analyses (CEAs) have been performed for oral non-disease-altering osteoarthritis (OA) treatments for well over a decade. During that period the methods for performing these analyses have evolved as pharmacoeconomic methods have advanced, new treatments have been introduced, and the knowled...

journal_title：Applied health economics and health policy

authors： Wielage RC,Myers JA,Klein RW,Happich M

更新日期：2013-12-01 00:00:00

abstract：BACKGROUND:Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conventional amphotericin B (CAB). Prior studies have suggested...

journal_title：Applied health economics and health policy

authors： Yang H,Chaudhari P,Zhou ZY,Wu EQ,Patel C,Horn DL

更新日期：2014-02-01 00:00:00

abstract：BACKGROUND:Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the UK, and highlight a current shortfall in the prescription of anticoagulants to patients with AF for stroke prevention. OBJECTIVE:To design a budget impact model...

journal_title：Applied health economics and health policy

authors： Shields GE,Bates AE,Chapman AM

更新日期：2015-10-01 00:00:00

abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...

journal_title：Applied health economics and health policy

authors： Jarrett J,Mugford M

更新日期：2006-01-01 00:00:00

abstract：OBJECTIVES:The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact of critical parameters on incremental costs and quality-adjusted life...

journal_title：Applied health economics and health policy

authors： Vreman RA,Geenen JW,Hövels AM,Goettsch WG,Leufkens HGM,Al MJ

更新日期：2019-12-01 00:00:00

abstract：BACKGROUND:European guidelines advocate the measurement of on-treatment hepatitis C virus (HCV) RNA in order to determine optimal therapy duration (response-guided therapy [RGT]) in patients with rapid virological response (RVR) or delayed virological response (DVR). Treatment response is highly dependent upon the exte...

journal_title：Applied health economics and health policy

authors： McEwan P,Kim R,Yuan Y

更新日期：2013-02-01 00:00:00

abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

journal_title：Applied health economics and health policy

authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

更新日期：2017-02-01 00:00:00

abstract：OBJECTIVES:The aim of this study was to review all published economic evaluations of guideline-based care for chronic wounds and to assess how useful these studies are for decision making in health services. METHODS:Embase, PubMed, Scopus, Health Technology Assessment (HTA) and National Health Service Economic Evaluat...

journal_title：Applied health economics and health policy

authors： Cheng Q,Graves N,Pacella RE

更新日期：2018-10-01 00:00:00

abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...

journal_title：Applied health economics and health policy

authors： Andronis L,Kinghorn P,Qiao S,Whitehurst DG,Durrell S,McLeod H

更新日期：2017-04-01 00:00:00

abstract：OBJECTIVES:The aim of this review is to assess the current state of empirical research regarding the effectiveness of national pricing regulations of the patent-protected market for prescription pharmaceuticals. Effectiveness is understood to be the capacity of policies to have a desired impact on outcomes, such as hea...

journal_title：Applied health economics and health policy

authors： Wettstein DJ,Boes S

更新日期：2019-04-01 00:00:00

abstract：BACKGROUND:Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good cov...

journal_title：Applied health economics and health policy

authors： Rubio-Terrés C,Soria JM,Morange PE,Souto JC,Suchon P,Mateo J,Saut N,Rubio-Rodríguez D,Sala J,Gracia A,Pich S,Salas E

更新日期：2015-04-01 00:00:00

abstract：BACKGROUND:The Xpert® MTB/RIF (Xpert) test has been shown to be effective and cost-effective for diagnosing tuberculosis (TB) under conditions with high HIV prevalence and HIV-TB co-infection but less is known about Xpert's cost in low HIV prevalence settings. Cambodia, a country with low HIV prevalence (0.7%), high TB...

journal_title：Applied health economics and health policy

authors： Pallas SW,Courey M,Hy C,Killam WP,Warren D,Moore B

更新日期：2018-08-01 00:00:00

abstract：BACKGROUND:Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is known about the economic burden associated with PAH patients in the US. OBJECTIVES:The objective of this study was to estimate excess direct costs associated with privately insured PAH patients in the US. METHODS:From a privately ...

journal_title：Applied health economics and health policy

authors： Kirson NY,Birnbaum HG,Ivanova JI,Waldman T,Joish V,Williamson T

更新日期：2011-09-01 00:00:00

abstract：OBJECTIVES:To describe how post-market utilisation analysis in Australia informs cost-effectiveness assessment and pricing decisions, using aflibercept and ranibizumab as case studies. METHODS:Pharmaceutical claims were used to identify initiators of aflibercept and ranibizumab in the year after aflibercept-listing (D...

journal_title：Applied health economics and health policy

authors： Kemp-Casey A,Pratt N,Ramsay E,Roughead EE

更新日期：2019-06-01 00:00:00

abstract：OBJECTIVE:To develop a statistical model generating utility estimates for prostate cancer specific health states, using preference weights derived from the perspectives of prostate cancer patients, men at risk for prostate cancer, and society. METHODS:Utility estimate values were calculated using standard gamble (SG) ...

journal_title：Applied health economics and health policy

authors： Gries KS,Regier DA,Ramsey SD,Patrick DL

更新日期：2017-06-01 00:00:00

abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...

journal_title：Applied health economics and health policy

authors： Mason AR,Drummond MF,Hunter JA,Towse AK,Cooke J

更新日期：2005-01-01 00:00:00

abstract：:The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluat...

journal_title：Applied health economics and health policy

authors： Dale M,Morgan H,Carter K,White J,Carolan-Rees G

更新日期：2019-02-01 00:00:00

abstract：:This paper examines the use of propensity score matching in economic analyses of observational data. Several excellent papers have previously reviewed practical aspects of propensity score estimation and other aspects of the propensity score literature. The purpose of this paper is to compare the conceptual foundation...

journal_title：Applied health economics and health policy

authors： Crown WH

更新日期：2014-02-01 00:00:00

abstract：:Health state utility values are a major source of uncertainty in economic evaluations of interventions for age-related macular degeneration (AMD). This review identifies and critiques published utility values and methods for eliciting de novo utility values in AMD. We describe how utility values have been used in heal...

journal_title：Applied health economics and health policy

authors： Butt T,Tufail A,Rubin G

更新日期：2017-02-01 00:00:00